Jun 30, 2014

ANI Pharmaceuticals Q2 2014 Earnings Report

Total Revenue
$6.65M
Previous year: $6.15M
+8.1%
EPS
-$0.21
Previous year: -$16
-98.7%
Gross Profit
$4.53M
Previous year: $4.05M
+11.8%
Cash and Equivalents
$53M
Previous year: $12.6M
+320.5%
Free Cash Flow
$1.7M
Previous year: -$1.01M
-268.8%
Total Assets
$95.4M
Previous year: $41.7M
+129.1%

ANI Pharmaceuticals

ANI Pharmaceuticals